Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112909602 | 11290960 | 2 | F | 201501 | 20150717 | 20150722 | 20160928 | EXP | US-UNITED THERAPEUTICS-UNT-2015-000163 | UNITED THERAPEUTICS | 44.01 | YR | M | Y | 77.98000 | KG | 20160928 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112909602 | 11290960 | 1 | PS | REMODULIN | TREPROSTINIL | 1 | Intravenous drip | 0.0515 ?G/KG, CONTINUING | U | U | 924065 | 21272 | .051 | UG/KG | INJECTION | ||||
| 112909602 | 11290960 | 2 | SS | REMODULIN | TREPROSTINIL | 1 | Intravenous drip | 0.060 ?G/KG, CONTINUING | U | U | 2100499 | 21272 | .06 | UG/KG | INJECTION | ||||
| 112909602 | 11290960 | 3 | SS | LETAIRIS | AMBRISENTAN | 1 | 10 MG, QD | 1309762A | 0 | 10 | MG | QD | |||||||
| 112909602 | 11290960 | 4 | SS | LETAIRIS | AMBRISENTAN | 1 | 0 | ||||||||||||
| 112909602 | 11290960 | 5 | C | ADCIRCA | TADALAFIL | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112909602 | 11290960 | 1 | Pulmonary arterial hypertension |
| 112909602 | 11290960 | 3 | Pulmonary hypertension |
| 112909602 | 11290960 | 4 | Drug abuse |
| 112909602 | 11290960 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112909602 | 11290960 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112909602 | 11290960 | Dermatitis contact | |
| 112909602 | 11290960 | Device related infection | |
| 112909602 | 11290960 | Dyspnoea | |
| 112909602 | 11290960 | Infection | |
| 112909602 | 11290960 | Injection site infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112909602 | 11290960 | 1 | 20140516 | 0 | ||
| 112909602 | 11290960 | 2 | 20140516 | 0 | ||
| 112909602 | 11290960 | 3 | 20111130 | 0 |